Smartleaf Asset Management’s GSK GSK Stock Holding History

Smartleaf Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08M	Hold	20,367	–	–	0.04%	405
2026 Q1	$1.1M	Buy	20,367 +5,484	+37%	+$297K	0.04%	384
2025 Q4	$734K	Buy	14,883 +793	+6%	+$37K	0.03%	445
2025 Q3	$579K	Buy	14,090 +5,574	+65%	+$218K	0.04%	448
2025 Q2	$329K	Sell	8,516 -476	-5%	-$18.2K	0.03%	459
2025 Q1	$348K	Sell	8,992 -2,954	-25%	-$108K	0.03%	438
2024 Q4	$402K	Buy	11,946 +4,746	+66%	+$171K	0.04%	370
2024 Q3	$293K	Buy	7,200 +2,431	+51%	+$99.5K	0.04%	391
2024 Q2	$184K	Buy	4,769 +1,690	+55%	+$71.1K	0.03%	403
2024 Q1	$132K	Buy	3,079 +2,410	+360%	+$99.4K	0.03%	456
2023 Q4	$25.1K	Buy	+669	New	+$24K	0.01%	640

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Smartleaf Asset Management's GSK Position: Q2 2026 in Review

Smartleaf Asset Management held its GSK (GSK) position steady in Q2 2026 at 20,367 shares worth $1.08M. The position accounts for 0.04% of the portfolio, ranked #405.

Smartleaf Asset Management first reported a position in GSK in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.1M in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Smartleaf Asset Management held 20,367 shares of GSK worth $1.08M as of Q2 2026.
Smartleaf Asset Management left its GSK share count unchanged in Q2 2026.
GSK made up 0.04% of Smartleaf Asset Management's portfolio in Q2 2026, its #405 holding.
Smartleaf Asset Management first reported a position in GSK in Q4 2023 and has held it in 11 quarters since.
Smartleaf Asset Management's GSK position peaked at $1.1M in Q1 2026.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.